Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Serina Therapeutics (SER) Interest Income - Total (2024 - 2025)

Serina Therapeutics' Interest Income - Total history spans 2 years, with the latest figure at $68000.0 for Q2 2025.

  • For Q2 2025, Interest Income - Total rose 21.43% year-over-year to $68000.0; the TTM value through Jun 2025 reached $258000.0, changed N/A, while the annual FY2024 figure was $235000.0, 16.96% down from the prior year.
  • Interest Income - Total for Q2 2025 was $68000.0 at Serina Therapeutics, up from $47000.0 in the prior quarter.
  • Across five years, Interest Income - Total topped out at $87000.0 in Q1 2024 and bottomed at $47000.0 in Q1 2025.